Omnio Healer AB
Developing regenerative plasminogen therapy to heal chronic wounds effectively.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2011
- Founded
Key Decision Makers
Charlotta Gummeson
Senior life science executive
Thomas Würdinger
Professor Neuroscience, biotech entrepreneur
Tor Ny
Founder – Head of RnD
Felipe Velasquez
CEO
+6 more contacts in Funnelfeedr
Description
Omnio is a biotechnology company focused on revolutionizing chronic wound care. They are developing a next-generation, regenerative therapy utilizing recombinant plasminogen to treat wounds that resist standard care, such as diabetic foot ulcers. This therapy aims to restart the body's stalled natur...